Center for Autism and Related Disorders (CARD) and Lineagen, Inc. today announced the launch of a new clinical partnership to offer Lineagen’s FirstStepDx® genetic test to patients and their families. FirstStepDx is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs. Under the terms of the partnership agreement, FirstStepDx, integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD’s innovative Skills® program. The program is the first of its kind, designed to fully meet current clinical guidelines that recommend chromosomal microarray analysis as a first-line genetic test as part of a comprehensive diagnostic evaluation of individuals with ASDs.
December 2014 M T W T F S S « Mar 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
- Holly Robinson Peete Opens Up on Autism Live About Motherhood, the Teen Years and the Future of Autism
- CARD to Host Free Colorado Conference to Provide Treatment Solutions to Families Affected by Autism
- CARD Partners with AutismUp to Help Rochester Parents Gain Access to Autism Insurance Coverage
- Dr. Doreen Granpeesheh Testifies For California Autism Insurance Mandate